Piper Sandler Reiterates Overweight Rating on Gossamer Bio Inc. (GOSS)

September 12, 2024 7:43 AM UTC Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $15.00 price target on Gossamer Bio Inc. (NASDAQ: GOSS).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login